Abdominal Imaging in ADPKD: Beyond Total Kidney Volume
Journal of Clinical Medicine · 05.08.2023 · 12 (15) · 5133
DOI: 10.3390/jcm12155133 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.08.2023. Verfasst von Anna Caroli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24020 Ranica, BG, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Italian Polycystic Kidney Association, National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.
Abstract (Originalsprache)
In the context of autosomal dominant polycystic kidney disease (ADPKD), measurement of the total kidney volume (TKV) is crucial. It acts as a marker for tracking disease progression, and evaluating the effectiveness of treatment strategies. The TKV has also been recognized as an enrichment biomarker and a possible surrogate endpoint in clinical trials. Several imaging modalities and methods are available to calculate the TKV, and the choice depends on the purpose of use. Technological advancements have made it possible to accurately assess the cyst burden, which can be crucial to assessing the disease state and helping to identify rapid progressors. Moreover, the development of automated algorithms has increased the efficiency of total kidney and cyst volume measurements. Beyond these measurements, the quantification and characterization of non-cystic kidney tissue shows potential for stratifying ADPKD patients early on, monitoring disease progression, and possibly predicting renal function loss. A broad spectrum of radiological imaging techniques are available to characterize the kidney tissue, showing promise when it comes to non-invasively picking up the early signs of ADPKD progression. Radiomics have been used to extract textural features from ADPKD images, providing valuable information about the heterogeneity of the cystic and non-cystic components. This review provides an overview of ADPKD imaging biomarkers, focusing on the quantification methods, potential, and necessary steps toward a successful translation to clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24020 Ranica, BG, Italy.
- Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Anna Caroli
Förderung
- NIDDK NIH HHS
- Italian Polycystic Kidney Association
- National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health
Zitieren
APA
Caroli, A., & Kline, T. L. (2023). Abdominal Imaging in ADPKD: Beyond Total Kidney Volume. Journal of Clinical Medicine, 12(15), 5133. https://doi.org/10.3390/jcm12155133
Vancouver
Caroli A, Kline TL. Abdominal Imaging in ADPKD: Beyond Total Kidney Volume. Journal of Clinical Medicine. 2023;12(15):5133. doi:10.3390/jcm12155133
BibTeX
@article{Caroli2023,
author = {Caroli, Anna and Kline, Timothy L},
title = {Abdominal Imaging in ADPKD: Beyond Total Kidney Volume},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {15},
pages = {5133},
doi = {10.3390/jcm12155133}
}
EUVIMED